Kyverna Therapeutics Stock (NASDAQ: KYTX) stock price, news, charts, stock research, profile.
You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.
Other companies in Kyverna Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Adaptimmune Therapeutics (NASDAQ:ADAP), Fate Therapeutics (NASDAQ:FATE), TScan Therapeutics (NASDAQ:TCRX) and Lyell Immunopharma (NASDAQ:LYEL).
Kyverna Therapeutics has a consensus price target of $23.20.
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $3.36 last updated January 17, 2025 at 7:48 PM EST.
There are no upcoming dividends for Kyverna Therapeutics.
Kyverna Therapeutics’s Q4 earnings are confirmed for Wednesday, February 12, 2025.
There is no upcoming split for Kyverna Therapeutics.
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.